1. Xu P, Chen Y, Ye X. Haze, air pollution, and health in China. Lancet. 2013; 382:2067.
2. Jin Q, Fang X, Wen B, Shan A. Spatio-temporal variations of PM2.5 emission in China from 2005 to 2014. Chemosphere. 2017; 183:429–436.
3. Li M, Zhang L. Haze in China: current and future challenges. Environ Pollut. 2014; 189:85–86.
4. Guan WJ, Zheng XY, Chung KF, Zhong NS. Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action. Lancet. 2016; 388:1939–1951.
5. Keleş N, Ilicali C. The impact of outdoor pollution on upper respiratory diseases. Rhinology. 1998; 36:24–27.
6. Zhang Y, Zhang L. Prevalence of allergic rhinitis in china. Allergy Asthma Immunol Res. 2014; 6:105–113.
7. Chen F, Lin Z, Chen R, Norback D, Liu C, Kan H, et al. The effects of PM2.5 on asthmatic and allergic diseases or symptoms in preschool children of six Chinese cities, based on China, children, homes and health (CCHH) project. Environ Pollut. 2018; 232:329–337.
8. Stevens WW, Lee RJ, Schleimer RP, Cohen NA. Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol. 2015; 136:1442–1453.
9. Ramanathan M Jr, London NR Jr, Tharakan A, Surya N, Sussan TE, Rao X, et al. Airborne particulate matter induces nonallergic eosinophilic sinonasal inflammation in mice. Am J Respir Cell Mol Biol. 2017; 57:59–65.
10. Chen Y, Wong GW, Li J. Environmental exposure and genetic predisposition as risk factors for asthma in China. Allergy Asthma Immunol Res. 2016; 8:92–100.
11. Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet. 2014; 383:1581–1592.
12. Ni L, Chuang CC, Zuo L. Fine particulate matter in acute exacerbation of COPD. Front Physiol. 2015; 6:294.
13. Krämer U, Koch T, Ranft U, Ring J, Behrendt H. Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology. 2000; 11:64–70.
14. Watelet JB, Gevaert P, Holtappels G, Van Cauwenberge P, Bachert C. Collection of nasal secretions for immunological analysis. Eur Arch Otorhinolaryngol. 2004; 261:242–246.
15. World Health Organization, Regional Office for Europe. Air quality guidelines global update 2005: particulate matter, ozone, nitrogen dioxide and sulfur dioxide. Copenhagen: WHO Regional Office for Europe;2006.
16. Inoue Y, Sato S, Manabe T, Makita E, Chiyotanda M, Takahashi K, et al. Measurement of exhaled nitric oxide in children: a comparison between NObreath® and NIOX VERO® analyzers. Allergy Asthma Immunol Res. 2018; 10:478–489.
17. American Thoracic Society. European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005; 171:912–930.
18. Scarpa MC, Kulkarni N, Maestrelli P. The role of non-invasive biomarkers in detecting acute respiratory effects of traffic-related air pollution. Clin Exp Allergy. 2014; 44:1100–1118.
19. Nightingale JA, Rogers DF, Barnes PJ. Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects. Thorax. 1999; 54:1061–1069.
20. Olin AC, Stenfors N, Torén K, Blomberg A, Helleday R, Ledin MC, et al. Nitric oxide (NO) in exhaled air after experimental ozone exposure in humans. Respir Med. 2001; 95:491–495.
21. Biewenga J, Stoop AE, Baker HE, Swart SJ, Nauta JJ, van Kamp GJ, et al. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations. Ann Clin Biochem. 1991; 28:260–266.
22. Steerenberg PA, Nierkens S, Fischer PH, van Loveren H, Opperhuizen A, Vos JG, et al. Traffic-related air pollution affects peak expiratory flow, exhaled nitric oxide, and inflammatory nasal markers. Arch Environ Health. 2001; 56:167–174.
23. Barraza-Villarreal A, Sunyer J, Hernandez-Cadena L, Escamilla-Nuñez MC, Sienra-Monge JJ, Ramírez-Aguilar M, et al. Air pollution, airway inflammation, and lung function in a cohort study of Mexico City schoolchildren. Environ Health Perspect. 2008; 116:832–838.
24. Romieu I, Barraza-Villarreal A, Escamilla-Nuñez C, Almstrand AC, Diaz-Sanchez D, Sly PD, et al. Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma. J Allergy Clin Immunol. 2008; 121:903–909.e6.
25. Wu W, Peden DB, McConnell R, Fruin S, Diaz-Sanchez D. Glutathione-S-transferase M1 regulation of diesel exhaust particle-induced pro-inflammatory mediator expression in normal human bronchial epithelial cells. Part Fibre Toxicol. 2012; 9:31.
26. Bernstein DI. Diesel exhaust exposure, wheezing and sneezing. Allergy Asthma Immunol Res. 2012; 4:178–183.
27. Smarr CB, Bryce PJ, Miller SD. Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Crit Rev Immunol. 2013; 33:389–414.
28. Wawrzyniak M, O'Mahony L, Akdis M. Role of regulatory cells in oral tolerance. Allergy Asthma Immunol Res. 2017; 9:107–115.
29. Baraniuk JN, Lundgren JD, Okayama M, Goff J, Mullol J, Merida M, et al. Substance P and neurokinin A in human nasal mucosa. Am J Respir Cell Mol Biol. 1991; 4:228–236.
30. Hanf G, Schierhorn K, Brunnée T, Noga O, Verges D, Kunkel G. Substance P induced histamine release from nasal mucosa of subjects with and without allergic rhinitis. Inflamm Res. 2000; 49:520–523.
31. Kaliner MA. The physiology and pathophysiology of the parasympathetic nervous system in nasal disease: an overview. J Allergy Clin Immunol. 1992; 90:1044–1045.
32. Kim DH, Park IH, Cho JS, Lee YM, Choi H, Lee HM. Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis. Am J Rhinol Allergy. 2011; 25:e44–7.
33. Baraniuk JN, Castellino S, Lundgren JD, Goff J, Mullol J, Merida M, et al. Neuropeptide Y (NPY) in human nasal mucosa. Am J Respir Cell Mol Biol. 1990; 3:165–173.
34. Raap U, Braunstahl GJ. The role of neurotrophins in the pathophysiology of allergic rhinitis. Curr Opin Allergy Clin Immunol. 2010; 10:8–13.
35. Knipping S, Holzhausen HJ, Riederer A, Schrom T. Allergic and idiopathic rhinitis: an ultrastructural study. Eur Arch Otorhinolaryngol. 2009; 266:1249–1256.
36. Sanico AM, Stanisz AM, Gleeson TD, Bora S, Proud D, Bienenstock J, et al. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am J Respir Crit Care Med. 2000; 161:1631–1635.
37. Wang H, Song L, Ju W, Wang X, Dong L, Zhang Y, et al. The acute airway inflammation induced by PM2.5 exposure and the treatment of essential oils in Balb/c mice. Sci Rep. 2017; 7:44256.
38. De Falco G, Colarusso C, Terlizzi M, Popolo A, Pecoraro M, Commodo M, et al. Chronic obstructive pulmonary disease-derived circulating cells release IL-18 and IL-33 under ultrafine particulate matter exposure in a caspase-1/8-independent manner. Front Immunol. 2017; 8:1415.
39. Srivastava A, Sharma A, Yadav S, Flora SJ, Dwivedi UN, Parmar D. Gene expression profiling of candidate genes in peripheral blood mononuclear cells for predicting toxicity of diesel exhaust particles. Free Radic Biol Med. 2014; 67:188–194.
40. Chen B, Lu S, Li S, Wang B. Impact of fine particulate fluctuation and other variables on Beijing's air quality index. Environ Sci Pollut Res Int. 2015; 22:5139–5151.
41. Burte E, Leynaert B, Bono R, Brunekreef B, Bousquet J, Carsin AE, et al. Association between air pollution and rhinitis incidence in two European cohorts. Environ Int. 2018; 115:257–266.